Our Orthopaedic portfolio provides our customers with a comprehensive range of surgical solutions, from Primary Total Joint replacement to solutions for extensive revision surgery.

Our Orthopaedic Products


Medacta has pioneered minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (“AMIS”) approach for hip replacements. With Medacta’s patient-matched, 3D printed technology, Surgeons can offer patients solutions tailored to their anatomy allowing for greater accuracy.


Suplasyn® is indicated as a viscoelastic supplement for small synovial joints. It is administered intra-articularly into the synovial space of affected joint (e.g. knee, hip, toe, ankle, thumb). Suplasyn® has been shown to be beneficial in osteoarthritis for the management of pain and improvement in physical function of joints.


The Quill barbed suture is a time-saving closure device that eliminates the need to tie knots to secure the closure. The barbed design evenly distributes tension offering a unique combination of security and speed—increasing both efficiency and value.


Until now, Platelet Rich Plasma (PRP) systems were unable to sustain the mononuclear cell population while eliminating the RBC and neutrophils. However, Tropocells® advanced gel separation technology removes the cells that promote inflammation and catabolism while producing a solution rich in platelets and monocytes optimising healing and growth.


LockDown is a synthetic device used in acromioclavicular reconstruction to replace the ligament and recreate the anatomy. It is made of double braided polyester, with a tensile strength of 1730N. There are over 3,000 implantations being made every year worldwide. LockDown allows early mobilisation at 2 weeks, quick rehabilitation – with light exercise at 8 weeks and contact sport at 12 weeks.